JR
John C Reed (EVP, Innovative Medicine, R&D) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Johnson & Johnson (JNJ). The largest single filing was $13.1M of JNJ (53,931 sh across 3 lots, as filed), executed Feb 17. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$13.1M
shares × price, as filed
Last traded
Feb 17
Filed Feb 18
Median ADV $2.2B across their filed names
Open performance→Volume by month
Buys $0
Sells $20.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
JNJ
Johnson & Johnson
JNJ · 0 buys · 3 sells
3 filings
Recent filings
JNJSALE
Johnson & Johnson
View filing →
$13.1M53,931 sh across 3 lots
Exec Feb 17
Filed Feb 18 · 5:30 PM ET JNJSALE Johnson & Johnson View filing → $4.2M
21,721 sh × $192.71
Exec Oct 17 2025
Filed Oct 20 2025 · 5:30 PM ET JNJSALE Johnson & Johnson View filing → $3.1M
19,137 sh × $163.55
Exec Jul 17 2025
Filed Jul 18 2025 · 5:30 PM ET